Segall Bryant & Hamill LLC Acquires 21,760 Shares of McKesson Co. (NYSE:MCK)

Segall Bryant & Hamill LLC grew its holdings in shares of McKesson Co. (NYSE:MCK - Free Report) by 50.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 64,721 shares of the company's stock after buying an additional 21,760 shares during the period. Segall Bryant & Hamill LLC's holdings in McKesson were worth $31,999,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. RFP Financial Group LLC boosted its holdings in shares of McKesson by 9.8% during the 2nd quarter. RFP Financial Group LLC now owns 191 shares of the company's stock valued at $112,000 after buying an additional 17 shares in the last quarter. Modera Wealth Management LLC raised its position in shares of McKesson by 2.2% in the 2nd quarter. Modera Wealth Management LLC now owns 804 shares of the company's stock worth $470,000 after purchasing an additional 17 shares during the last quarter. Larson Financial Group LLC raised its position in shares of McKesson by 1.6% in the 2nd quarter. Larson Financial Group LLC now owns 1,094 shares of the company's stock worth $639,000 after purchasing an additional 17 shares during the last quarter. First Western Trust Bank raised its position in shares of McKesson by 2.0% in the 1st quarter. First Western Trust Bank now owns 913 shares of the company's stock worth $490,000 after purchasing an additional 18 shares during the last quarter. Finally, Lester Murray Antman dba SimplyRich raised its position in shares of McKesson by 0.4% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 5,026 shares of the company's stock worth $2,935,000 after purchasing an additional 19 shares during the last quarter. Institutional investors own 85.07% of the company's stock.

Analysts Set New Price Targets

Several research firms recently commented on MCK. Evercore ISI lifted their price objective on McKesson from $560.00 to $680.00 and gave the stock an "outperform" rating in a report on Thursday, November 7th. JPMorgan Chase & Co. lifted their price objective on McKesson from $656.00 to $661.00 and gave the stock an "overweight" rating in a report on Wednesday, August 21st. Mizuho lifted their price objective on McKesson from $540.00 to $570.00 and gave the stock a "neutral" rating in a report on Thursday, August 8th. Citigroup lifted their price objective on McKesson from $630.00 to $713.00 and gave the stock a "buy" rating in a report on Wednesday, November 13th. Finally, Baird R W upgraded McKesson from a "hold" rating to a "strong-buy" rating in a research note on Thursday, November 7th. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $631.57.

McKesson Stock Up 1.0 %

NYSE MCK traded up $5.87 during trading hours on Wednesday, reaching $621.52. The company's stock had a trading volume of 151,991 shares, compared to its average volume of 819,890. The firm's 50-day moving average price is $524.33 and its 200-day moving average price is $555.78. McKesson Co. has a 1 year low of $431.35 and a 1 year high of $637.51. The company has a market capitalization of $78.90 billion, a price-to-earnings ratio of 31.87, a PEG ratio of 1.31 and a beta of 0.44.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 EPS for the quarter, topping analysts' consensus estimates of $6.88 by $0.19. The company had revenue of $93.65 billion for the quarter, compared to analysts' expectations of $89.33 billion. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The firm's revenue was up 21.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.23 EPS. Equities research analysts anticipate that McKesson Co. will post 32.81 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd will be issued a dividend of $0.71 per share. The ex-dividend date is Monday, December 2nd. This represents a $2.84 annualized dividend and a dividend yield of 0.46%. McKesson's dividend payout ratio (DPR) is 14.71%.

Insider Transactions at McKesson

In other news, CEO Brian S. Tyler sold 3,753 shares of the business's stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the transaction, the chief executive officer now owns 78,586 shares of the company's stock, valued at approximately $44,094,604.60. The trade was a 4.56 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.11% of the company's stock.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.